Literature DB >> 17437621

Intracranial dissemination of primary spinal cord anaplastic oligodendroglioma.

C Ramirez1, O Delrieu, J-F Mineo, G Paradot, M Allaoui, F Dubois, S Blond.   

Abstract

We report the first case of a 22-year-old man, with a previously neurosurgically treated intramedullary anaplastic oligodendroglioma (World Health Organization grade III), who developed 19 months later two histologically proven intracranial metastases. We support a hypothesis whereby the anaplastic parts of tumors have spread along the spinal cord and brainstem via the cerebrospinal fluid pathways, a process that could be promoted by surgical manipulation, although the relative contribution of the two factors remains speculative.

Entities:  

Mesh:

Year:  2007        PMID: 17437621     DOI: 10.1111/j.1468-1331.2006.01701.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  5 in total

1.  Primary Spinal Cord Oligodendroglioma with Postoperative Adjuvant Radiotherapy: A Case Report.

Authors:  Woon Tak Yuh; Chun Kee Chung; Sung-Hye Park
Journal:  Korean J Spine       Date:  2015-09-30

Review 2.  Hydrocephalus and spinal cord tumors: a review.

Authors:  Giuseppe Mirone; Giuseppe Cinalli; Pietro Spennato; Claudio Ruggiero; Ferdinando Aliberti
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

3.  Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide.

Authors:  Fulin Wang; Guangyu Qiao; Xin Lou
Journal:  J Neurooncol       Date:  2010-12-29       Impact factor: 4.130

4.  A very rare spinal cord tumor primary spinal oligodendroglioma: A review of sixty cases in the literature.

Authors:  Askin Esen Hasturk; Emre Cemal Gokce; Cagri Elbir; Gulce Gel; Suat Canbay
Journal:  J Craniovertebr Junction Spine       Date:  2017 Jul-Sep

Review 5.  Holocord oligodendroglioma with intracranial extension in a young adult: a case report and review of literature.

Authors:  Romulus Emmanuel H Cruz; Ranhel C De Roxas; Carmela Concepcion A Sales-Callangan; Roland Dominic G Jamora
Journal:  CNS Oncol       Date:  2018-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.